HPTLC method for simultaneous determination of lopinavir and ritonavir in capsule dosage form

E-Journal of Chemistry

Volumn 5, Issue 4, 2008, Pages 706-712

  Sulebhavikar, A V ^a   Pawar, U D ^b   Mangoankar, K V ^b   Prabhu Navelkar, N D ^b  

^a K J Somaiya College of Engineering   (India)

^b INSTITUTE OF SCIENCE   (India)

Author keywords

HPTLC; Lopinavir; Pharmaceutical formulation; Ritonavir

Indexed keywords

EID: 57349113099     PISSN: None     EISSN: 09734945     Source Type: Journal    
DOI: 10.1155/2008/539849     Document Type: Article

References (28)

1. George Lunn, HPLC Methods for Pharmaceutical Analysis, 1996, 4, 795.
2. Susan Budavari, Maryadele J O' Neil, Ann Smith, Patricia E. Heckelman and Joanne F Kinneary, The Merck Index, 12th Ed., Monograph No. 8402, Merck, USA, 1996, 1418.
3. Corett A H, Lim L M and Kashuba A D, Ann Pharmacother., 2002, 36, 1193.
4. Kumar G, N, Rodrigues A D, Buko A M and Denissen J F, J Pharmacol Exp Ther., 1996, 277, 423.
5. Kunar G N, Jayanti V, Lee R D, Whittern D N, Uchic J, Thomas S, Johnson P, Grabowski B, Sham H, Betebenner D, Kempf D J and Denissen J F, Drug Metab. Dispo., 1999, 27, 86
6. Adkins J C and Noble S, Drugs, 1998, 56, 1055.
7. ICH Q2A Text on Validation of analytical procedures, International Conference on Harmonization tripartite guidelines, adapted 27 Oct 1994.
8. st Edition, CBS Publishers and distributors, India, 1996.
9. rd Ed., Published by John wiley and sons, Inc., USA, 1992
10. nd Ed., CBS Publishers and distributors, USA, 1999.
11. ICH Q2B Text on validation of analytical procedures: Methodology International Conference on Harmonization Nov. 1996.
12. USAMI Yoshiko, O K. Tsuyoshi, NAKA Masahiko, SAGISAKA Masafumi and KANEDA Tsuguhiro, Chemical and Pharmaceutical Bulletin, 2003, 51, 715.
13. Rebiere H, Mazel B, Civade C and Bonnet PA., J Chromatogr B, 2006, 823 (1-2), 201.
14. Ray J, Pang E and Carey D, J Chromatogr B, 2002, 775(2), 225.
15. Kuschak D, Mauss S, Schmutz G and Gantke B, Clin Lab., 2001, 47(9-10), 471.
16. Takahashi M, Yoshida M, Oki T, Okumura N, Suzuki T and Kaneda T, Biol Pharm Bull., 2005, 28(7),1286.
17. Poirier J M, Radembino N, Robidou P and Jaillon P, Ther Drug Monit., 2000, 22(4), 465.
18. Dailly E, Thomas L, Kergueris M F, Jolliet P and Bourin M, J Chromatogr B, 2001, 758(2), 129.
19. Poirier J M, Robidou P and Jaillon P, Ther Drug Monit., 2002, 24(2), 302.
20. Bouley M, Briere C, Padoin C, Petitjean O and Tod M, Ther Drug Monit,, 2001, 23(1), 56.
21. Hugen P W, Verweij-van Wissen C P, Burger D M, Wuis E W, Koopmans P P and Hekster Y A, J Chromatogr B, 1999, 727(1-2), 139.
22. Van Heeswijk R P, Hoetelmans R M, Harms R, Meenhorst P L, Mulder J W, Lange J M and Beijnen JH, J Chromatogr B, 1998, 719(1-2), 159.
23. Remmel R P, Kawle S P, Weller D and Fletcher C V, Clin Chem., 2000, 46(1), 73.
24. Choi S O, Rezk N L and Kashuba A D, J Pharm Biomed Anal., 2007, 43(4), 1562.
25. Verbesselt R, Van Wijngaerden E and de Hoon J, J Chromatogr B, 2007, 845(1), 51.
26. Wang P G, Wei J S, Kim G, Chang M and El-Shourbagy T, J Chromatogr B, 2006, 1130(2), 302.
27. Chi J, Jayewardene A L, Stone J A, Motoya T and Aweeka F T, J. Pharm Biomed Anal., 2002, 30(3), 675.
28. Dickinson L, Robinson L, Tjia J, Khoo S and Back D, J Chromatogr B, 2005, 829 (1-2), 82.